Dual protein kinase C alpha and beta inhibitors and diabetic kidney disease: a revisited therapeutic target for future clinical trials.
Diabetology & Endocrinology Kanazawa Medical University Kahokugun Ishikawa Japan.
Daisuke
D
Koya